Saturday, November 1, 2025

Canada’s Politics and Government News Source Since 1989

Saturday, November 1, 2025 | Latest Paper

TRENDING:

Former PMO staffer Jaspreet Pandher was a friend to many on the Hill

Jaspreet Pandher, who died of cancer on Jan. 20, was an outreach officer in the Prime Minister's Office, but he was also a friend to many on the Hill, writes Vandana Kattar-Miller.

Opinion
BY VANDANA KATTAR-MILLER
May 15, 2023

Opinion | BY VANDANA KATTAR-MILLER | May 15, 2023

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Security delayed is security denied

OpinionBY LISA LAMBERT, MICHELE MOSCA

Who will protect our brains in the AI race?

OpinionBY VIVIANE POUPON

Carney’s budget challenge: govern for the many, or manage for the few?

OpinionBY BHAGWANT SANDHU

The easiest policy win in Ottawa might just be hiding in plain sight

OpinionBY ORVILLE BOVENSCHEN

For Canada to be ‘climate competitive’ we need to stay the course on key industrial policies

OpinionBY JANETTA MCKENZIE

Related Stories

Veterans raise inaugural poppy flag on Parliament Hill

FeatureBY ANDREW MEADE

All eyes on the Carney-Xi meeting

FeatureBY RIDDHI KACHHELA, PETER MAZEREEUW

Auditor General to probe Canada Revenue Agency’s phone system contract

NewsBY MARLO GLASS

Women’s groups hail ongoing funding for gender-equality programs, but warn the ‘devil is in the details’

NewsBY RIDDHI KACHHELA, SAMANTHA WRIGHT ALLEN

‘Cut through the table talk’: tech firms launch new group to help feds fix procurement woes

NewsBY IREM KOCA

Curing Type 1 diabetes could be Canada’s legacy

OpinionBY JESSICA DINIZ, CATE MURRAY

From insulin to regenerative therapy, Canada’s contribution to diabetes research is unmatched. The question is whether we’ll continue to lead or watch others cross the finish line.

Curing Type 1 diabetes could be Canada’s legacy

OpinionBY JESSICA DINIZ, CATE MURRAY

From insulin to regenerative therapy, Canada’s contribution to diabetes research is unmatched. The question is whether we’ll continue to lead or watch others cross the finish line.